Infectious Disease Diagnostic Market is Expanding to Reach US$ 2,978.7 Million by 2034 at a 7.1% CAGR | Fact.MR Report

The size of the global infectious disease diagnostic market is US$ 1,503.8 million in 2024 and is estimated to grow at a 7.1% CAGR to reach a valuation of US$ 2,978.7 million by 2034.

Molecular diagnostics, rapid testing, automation, and other technological advancements have significantly enhanced the accuracy, speed, and efficiency of diagnosing infectious diseases.

By providing better tools for the early detection and monitoring of infectious diseases, these innovations facilitate the growth of the market. Infectious diseases, particularly emerging and re-emerging infections, are becoming more widespread in the world. Consequently, there is an increased need for accuracy diagnostic technologies that allow for early detection and treatment.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9586

Key Takeaways from Market Study:

The market is valued at US$ 1,503.8 million in 2024 and will reach US$ 2,987.7 million by 2034 at a 7.1% CAGR.
The STDs indication segment will grow at a CAGR of 8.3% from 2024 to 2034.
The cell culture technique segment is set to expand at 8.3% CAGR through 2034.
North America will hold 20.9% of the market share in 2024.
East Asia is expected to account for 17.7% of the market in 2024.

Leading Players Driving Innovation in the Infectious Disease Diagnostic Market:

Roche Diagnostics; Abbott Laboratories; Siemens Healthineers; Thermo Fisher Scientific; BioMérieux SA; Becton, Dickinson and Company; Cepheid (a Danaher Corporation company); Hologic, Inc.; QIAGEN N.V.; Bio-Rad Laboratories, Inc.; Luminex Corporation; Ortho Clinical Diagnostics; DiaSorin S.p.A.; Meridian Bioscience, Inc.; GenMark Diagnostics, Inc.

Key Trends Driving Infectious Disease Diagnostic Market Growth

The increasing adoption of Point-of-Care Testing (POCT) reflects a conscious shift from centralized to decentralized diagnostic solutions, which allow businesses to respond to customers' needs for rapid and easy diagnostics.

This trend provides POCT solution-providing businesses with a competitive advantage through enabling faster decision-making and patient management. It also aligns with market demands for efficient healthcare delivery in resource-limited settings.

Companies involved in infectious disease diagnosis are leveraging Next-Generation Sequencing (NGS) technology advances. Companies are providing novel solutions to address growing demand for genetic diversity analysis in infectious pathogens and comprehensive surveillance use by incorporating faster and lower-cost sequencing options.

Browse Full Report: https://www.factmr.com/report/infectious-disease-diagnostic-market

More Valuable Insights on Offer:

Fact.MR, in its new offering, presents an unbiased analysis of the global infectious disease diagnostic market, presenting historical market data (2019-2023) and forecast statistics for the period of 2024-2034.

The infectious disease diagnostic market is segmented based on disease indication, technique, end user, and region. By disease indication, the market includes CNS infection, diarrhoeal disease, respiratory infections, blood infections, and STDs. Based on technique, it is categorized into ELISA, polymerase chain reaction, immunoassays, cell cultures, and others.

The market is further divided by end users, which consist of hospitals, diagnostic centers, clinics, and government organizations. Regionally, the market is analyzed across North America, Europe, Latin America, East Asia, South Asia & Oceania, and the Middle East & Africa.

Check out More Related Studies Published by Fact.MR Research:

Viral Disease Diagnosis Market - https://www.factmr.com/report/viral-disease-diagnosis-market

AI in Diagnostics Market - https://www.factmr.com/report/ai-in-diagnostics-market

Predictive Diagnostics Market - https://www.factmr.com/report/predictive-diagnostics-market

Human Prion Disease Diagnostics Market - https://www.factmr.com/report/human-prion-disease-diagnostics-market

Sepsis Diagnostics Market - https://www.factmr.com/report/391/sepsis-diagnostics-market

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team : sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog

Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.

This release was published on openPR.